B40.89
Other forms of blastomycosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis. While it most commonly affects the skin, lungs, and bones, there are other less typical forms of the disease classified under ICD-10 code B40.89, which encompasses various atypical presentations of blastomycosis. These unusual forms may involve different parts of the body or exhibit uncommon symptoms, making awareness and understanding crucial for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Exposure to environments contaminated with Blastomyces spores, such as decaying wood, soil, or organic matter in certain geographic regions. Inhalation of spores into the lungs, which is the most common transmission route. Less frequently, direct inoculation of spores through skin injuries or bites. Geographic distribution primarily includes regions in the United States, especially the Ohio and Mississippi River valleys and parts of Canada.
Key Symptoms: Respiratory issues such as cough, chest pain, and fever. Skin lesions ranging from ulcers, nodules, or verrucous plaques. Bone pain or swelling if the infection spreads to the skeletal system. Fatigue, weight loss, and malaise that may indicate systemic spread. Less common manifestations may involve the prostate, abdominal organs, or the central nervous system.
Diagnostic & Treatment
Diagnosis Path: Medical history review focusing on exposure risk and geographic location. Imaging studies like chest X-rays or CT scans to identify pulmonary involvement. Microscopic examination of tissue or fluid samples revealing broad-based budding yeast cells characteristic of Blastomyces. Fungal cultures from affected tissues, blood, or bodily fluids, which can take several days to weeks. Serological tests and molecular techniques such as PCR for enhanced detection, though these may not be routinely available.
Treatment Protocols: Itraconazole: Often the first line for mild to moderate disease cases. Amphotericin B: Used in severe or disseminated blastomycosis cases; available in deoxycholate or lipid formulations to reduce toxicity. Duration of therapy can range from several months to over a year, depending on disease severity and response to treatment. Monitoring and follow-up are essential to ensure complete resolution and prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is B40.89 a billable ICD-10 code?
Yes, B40.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B40.89?
Clinical documentation must specify the nature of Other forms of blastomycosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference